Table 1.
Description of TCGA-LIHC cohort
| Number of patients | 278 |
|---|---|
| Sex | |
| Male | 193 (69.42%) |
| Female | 85 (30.58%) |
| Age | |
| Median (range) | 59 (18-82) |
| aged < 60 | 141 (50.72%) |
| AJCC stage | |
| I | 139 (50.00%) |
| II | 67 (24.10%) |
| III | 69 (24.82%) |
| IV | 3 (1.08%) |
| Invasion | |
| Invasion | 77 (27.70%) |
| None | 201 (72.30%) |
| Mutations | |
| APOB | 34 (12.23%) |
| CSMD3 | 33 (11.87%) |
| MUC16 | 65 (23.38%) |
| MUC4 | 43 (15.47%) |
| PCLO | 38 (13.67%) |
| RYR2 | 37 (13.31%) |
| TP53 | 89 (32.01%) |